Internal Medicine, Cardiovascular Disease · Huntsville, AL
NPI
1952381444
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4700 Whitesburg Dr SE, Suite 200
Huntsville, AL, 35802
Phone (256) 882-1450
Groups this clinician bills Medicare through
Medicare paid, 2024
$617K
9,476 services
Medicare patients, 2024
1,334
Average age 76
Drug cost, 2024
$3.2M
13,947 prescriptions
Company payments, 2025
$674
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sadasiva R Katta was code 93000 (electrocardiogram), 1,889 times for 1,023 patients. In total Sadasiva R Katta billed 9,476 services in 70 codes, and Medicare paid $617K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,889 | 1,023 | $8.91 | $17K |
| 99214 Office E&M - Established | Office | 1,806 | 961 | $78.15 | $141K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,104 | 276 | $5.35 | $5,903 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 771 | 476 | $84.49 | $65K |
| 93306 Echocardiography (TTE/TEE) | Office | 662 | 650 | $121.12 | $80K |
| 93015 Electrocardiogram | Office | 479 | 479 | $43.90 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 319 | 151 | $85.91 | $27K |
| 78452 Myocardial Perfusion Scan | Office | 294 | 294 | $284.64 | $84K |
| 93306 Echocardiography (TTE/TEE) | Facility | 273 | 248 | $48.97 | $13K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 235 | 231 | $108.03 | $25K |
| 93294 External Electrocardiographic Monitoring | Office | 192 | 74 | $19.48 | $3,739 |
| 99223 Hospital E&M - Initial | Facility | 184 | 162 | $122.35 | $23K |
| 78451 Myocardial Perfusion Scan | Office | 182 | 182 | $201.15 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 173 | 80 | $56.78 | $9,823 |
| 93228 Electrocardiogram | Office | 109 | 109 | $16.03 | $1,747 |
By year: 2022 $778K for 10,605 services; 2023 $720K for 9,780 services; 2024 $617K for 9,476 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sadasiva R Katta prescribed most often to Medicare patients was Metoprolol Succinate, with 1,333 prescriptions and refills. In total Sadasiva R Katta wrote 13,947 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,333 | 3,798 | 425 | $24K |
| Atorvastatin Calcium Generic | 1,051 | 3,008 | 341 | $15K |
| Rosuvastatin Calcium Generic | 1,040 | 2,921 | 330 | $19K |
| Eliquis Apixaban | 782 | 1,617 | 192 | $913K |
| Losartan Potassium Generic | 704 | 1,987 | 230 | $7,974 |
| Amlodipine Besylate Generic | 644 | 1,868 | 224 | $4,161 |
| Entresto Sacubitril/Valsartan | 576 | 1,106 | 147 | $665K |
| Carvedilol Generic | 566 | 1,581 | 173 | $5,045 |
| Furosemide Generic | 553 | 1,467 | 186 | $2,377 |
| Ezetimibe Generic | 535 | 1,518 | 192 | $15K |
| Spironolactone Generic | 469 | 1,302 | 165 | $4,916 |
| Jardiance Empagliflozin | 361 | 736 | 100 | $391K |
| Clopidogrel Clopidogrel Bisulfate | 359 | 976 | 113 | $5,071 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 301 | 819 | 95 | $5,656 |
| Xarelto Rivaroxaban | 261 | 494 | 58 | $263K |
Brand drugs: 2,903 claims; generic drugs: 11,044 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sadasiva R Katta $674 ($674 in general payments such as food, travel and fees) from 15 companies. The largest payer was Novartis Pharmaceuticals Corporation with $149.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $149 |
| Esperion Therapeutics, Inc. ESPR | 6 | $111 |
| Merck Sharp & Dohme LLC MRK | 2 | $58.28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57.21 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $50.94 |
| Idorsia Pharmaceuticals US Inc | 3 | $45.46 |
| Amgen Inc. AMGN | 2 | $34.19 |
| Philips North America LLC PHG | 2 | $30.9 |
| Abbott Laboratories ABT | 1 | $24.89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.